Current through September 17, 2024
006.01
Qualifications for Class D Permit Holder
Class D permit holder qualifications for analysis by
chemical tests of an individual's urine for drug content are:
7-006.01A Be not less than the legal age of
majority as established by state statutes.
7-006.01B Have knowledge of the theory of the
instrument used for initial screens, the operation of the instrument, the
calibration of the instrument, the maintenance of the instrument, and the steps
in the technique of initial screen drug detection.
7-006.01C Have proof of knowledge and ability
consisting of a letter or certificate of training provided to the Department of
Health and Human Services from the instrument manufacturer certifying
attendance and completion of at least sixteen hours of training covering the
topics in 177 NAC
7-006.01B.
7-006.01D Have demonstrated competence to the
satisfaction of the Department of Health and Human Services. Satisfactory
competence shall be, for the purpose of these rules and regulations, the
satisfactory performance of analysis on proficiency samples in a performance
evaluation study as described in 177 NAC 7-006.03.
006.02 Issuance of Class D Permits for
Initial Screens
7-006.02A Applications for
Class D permits shall be made on forms provided by the Department of Health and
Human Services. The application shall be of the form as shown in Attachment 1,
attached and incorporated herein by reference.
7-006.02B An applicant for a Class D permit
shall, at the time of making application:
7-006.02B1 State the identity of the
method(s) that has been selected for use from the list of approved methods in
177 NAC 7-006.04.
7-006.02B2 Submit
the technique showing the written instructions which describes the procedure,
equipment, and equipment preventive maintenance schedule.
006.03 Performance Evaluation
Studies
A performance evaluation for permit issuance shall consist
of providing copies of the results of sample testing or the graded performance
from a recognized proficiency testing service.
For the purpose of these regulations an ASCLD-LAB approved
proficiency test provider must be used. Unacceptable performance is defined as
a false positive result for any drug in a one shipment survey.
7-006.03A Ongoing performance evaluation
studies shall be in effect, with acceptable performance, for test results to be
valid. Ongoing performance evaluation shall be enrollment in an ASCLD-LAB
approved drug proficiency testing program. Unacceptable performance is defined
as a false positive result for a drug in two successive survey shipments.
Copies of proficiency testing evaluations shall be provided to the Department
of Health and Human Services.
7-006.03B Initial screen testing shall not be
subject to participation in a recognized proficiency testing service as
specified in 177 NAC 7-006.03 and 177 NAC 7-006.03A. Initial screen permit
holders shall participate in a performance evaluation by the Department of
Health and Human Services. Unacceptable performance as defined in 177 NAC
7-006.03 applies to initial screen
permit applicants, and as defined in 177 NAC
7-006.03A for
ongoing performance evaluation surveys. An ongoing performance evaluation shall
be one survey shipment annually for initial screen permit holders.
7-006.03C Reporting of test results for the
presence or absence of drugs in the urine of individuals shall not occur by a
permit holder who has been notified of unacceptable performance in proficiency
testing.
7-006.03D A permit holder
shall be allowed two attempts to produce acceptable performance after being
notified of unacceptable performance.
7-006.03E A permit holder shall not resume
reporting of test results for the presence or absence of drugs in the urine of
individuals until the Department of Health and Human Services notifies a permit
holder that he/she is again in an acceptable performance status following
unacceptable performance.
006.04 List of Approved Methods and
Techniques for Initial Screen Testing
7-006.04A
ENZYME MULTIPLIED
IMMUNOASSAY TECHNIQUE (EMIT)
7-006.04A1 The enzyme multiplied immunoassay
technique is an approved initial screen method. Testing must be performed
according to the instrument manufacturer's instructions.
7-006.04B
FLUORESCENCE
POLARIZATION IMMUNOASSAY (FPIA).
7-006.04B1 The fluorescence polarization
immunoassay method u is an approved initial screen method. Testing must be
performed according to the instrument manufacturer's instructions.
006.05 Operating Rules
for Class D Permit
A Class 5 permit holder for the determination of drug
content in urine shall:
7-006.05A
Accept for testing only the specimen type of urine, as listed on the
permit.
7-006.05B Be responsible
for maintaining the legal continuity of all specimens received.
7-006.05C Perform all tests using the
approved method as named on the Class D permit and in a manner that consists of
the technique for the method as found in these rules and regulations.
7-006.05D Conduct all tests for each drug
with the inclusion of quality control samples in the test run. The test run may
include more than one person's sample for a particular drug; the quality
control samples shall be of the same drug that is tested in a test run. The
quality control sample result shall be used to:
7-006.05D1 Determine standard deviation data
computed as shown:
Click here to
view
7-006.05D2
Determine if test results are to be reported. No test results shall be reported
if a quality control sample result is outside of acceptable limits. Acceptable
limits for reporting test results shall be no greater than ± three
standard deviations, except for initial screen techniques that utilize an
instrument that does not produce numerical data.
7-006.05D3 The EMIT technique in 177 NAC
7-006.04A utilizes
an instrument that does not produce numerical data, therefore, no test result
shall be reported if a positive control sample does not give a positive result
or if a negative control sample does not give a negative result.
7-006.05F Maintain the following
records:
7-006.05F1 The permit to perform
chemical tests.
7-006.05F2 Records
of specimen receipts, tests performed and results.
7-006.05F3 The method and description of
technique steps in use by the permit holder along with documentation of
validation of technique.
7-006.05F4
The records of quality control results and related data as prescribed in 177
NAC
7-006.05D of this
subsection.
7-006.05F5 A current
copy of these rules and regulations.
7-006.05F6 The records of maintenance and
repair performed on an instrument, as prescribed in 177 NAC 7-006.06.
006.06 Maintenance and
Repair of Instruments
7-006.06A Maintenance
of instruments shall be performed as prescribed in the operators manual that is
intended for an instrument which may be utilized to produce results with a
technique in this regulation. Maintenance shall be performed by a person
trained by the manufacturer as specified in 177 NAC
7-006.01B and 177
NAC
7-006.01C.
Maintenance may also be performed by a manufacturer's representative.
7-006.06B Repair of an instrument shall be
performed by a manufacturer's representative or by a person trained by the
manufacturer.
7-006.06C
Malfunctions of instruments, maintenance activities, and repair occurrences
shall be recorded and shall show the name of the person and the agency or
business organization performing maintenance activities and repair
work.